BioRegen is Biotechnology in China that focus on drug delivery systems business. Founded in 2006. They cover business area such as developer, biomedical material, regenerative medicine, new drug delivery system, hyaluronic acid, ([dq]ha, base product, extracellular matrix material, hyaluronan, glycosaminoglycans, collagen, ENT, orthopedic, general surgery.
2006
( 18 years old in 2024 )
Drug Delivery Systems
-
Building B, Kangsite Industrial Park
117 Xuezhuan Road, Xinbei District
Changzhou, Jiangsu 213125
China
Private
developerbiomedical materialregenerative medicinenew drug delivery systemhyaluronic acid([dq]habase productextracellular matrix materialhyaluronanglycosaminoglycanscollagenENTorthopedicgeneral surgery
* We use standard office opening hours in near BioRegen's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
BioRegen is Biotechnology business from China that founded in 2006 (18 years old in 2024), BioRegen business is focusing on Drug Delivery Systems.
BioRegen headquarter office and corporate office address is located in Building B, Kangsite Industrial Park 117 Xuezhuan Road, Xinbei District Changzhou, Jiangsu 213125 China.
BioRegen was founded in China.
In 2024, BioRegen is currently focus on drug delivery systems sector.
Above is snippet of Google Trends for "drug delivery systems" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with BioRegen, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
